EMISPHERE TECHNOLOGIES INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-11-05: Reporting owner ROTHWELL TIMOTHY G; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-15: Reporting owner Novinski Michael V; Form 4; Security Incentive Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-15: Reporting owner RACHESKY MARK H MD; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-05-15: Reporting owner RACHESKY MARK H MD; Form 4; Security Non-Qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-11-05 | ROTHWELL TIMOTHY G Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.70 exercise price | 2009-11-12 | |
| 2009-05-15 | Novinski Michael V Director, Officer (President and CEO) | 4 | Incentive Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | RACHESKY MARK H MD Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | RACHESKY MARK H MD Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | MOCH KENNETH I Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | MOCH KENNETH I Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | HARKEY JOHN D JR Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | HARKEY JOHN D JR Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | BERGER FRANKLIN M Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | BERGER FRANKLIN M Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | WEISER MICHAEL Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-05-15 | WEISER MICHAEL Director | 4 | Non-Qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.93 exercise price | 2009-05-19 | |
| 2009-03-12 | Riley Gary Officer (VP, Nonclinical Dev & Appl Bio) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 95,000 owned after | $0.62 exercise price | 2010-01-21 | |
| 2009-03-12 | Garone Michael Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 95,000 owned after | $0.62 exercise price | 2010-01-21 |